ClinicalTrialsFinder

invasive fungal infection Clinical Trials in Brussels, Bruxelles-Capitale, Region de

1 recruitingBrussels, Bruxelles-Capitale, Region de, Belgium

Showing 1–1 of 1 trials

Recruiting
Phase 2

Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

invasive fungal infection
Merck Sharp & Dohme LLC40 enrolled26 locationsNCT04665037